Who bills the most Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (G0481) to Medicare in Florida?

31 physician groups billed Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (G0481) to Medicare fee-for-service in Florida in 2024; the top five named groups hold 67% of that volume, and independent (non-hospital-affiliated) groups deliver 0%.

G0481 — Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms · Source: CMS Medicare Physician & Other Practitioners PUF (Part B), CY2024 release. Medicare fee-for-service only.

Snapshot covers the whole Florida market — the table below shows the top 100 groups (free tier).

*Share of Florida's disclosed Medicare-FFS services for G0481, counted once per clinician. Volume is placed in the state it was billed from, so this page ranks the groups actually billing G0481 in Florida — including groups registered elsewhere ("City" is each group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group.